49 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
15 May 24
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
9:01am
and future laws and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other healthcare
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
regulatory scrutiny;
the effects of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our product
8-K
EX-99.1
8d7z1rde6n18vgpyo6
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
8-K
EX-99.1
vaqlk1mo8i ks65cyh
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
424B3
xyg pwgp1y03s7y
2 Feb 24
Prospectus supplement
12:00am
424B4
iqkcnq
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
oixnr7fp
5 Oct 23
Free writing prospectus
5:05pm
FWP
nwp8d366l0ct gmyml9
3 Oct 23
Free writing prospectus
5:47pm
424B3
a9cmcmbpv1v38sy
28 Jun 23
Prospectus supplement
4:56pm